Cardiovasc Revasc Med
-
Publication Venue For
- Global medical device clinical trials involving both the United States and Japan: Key considerations for development, regulatory approval, and conduct. 2023
- One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscape.. 45:67-73. 2022
- Mechanisms of Death in Low-Risk Patients After Transcatheter or Surgical Aortic Valve Replacement.. 42:1-5. 2022
- Impella Mechanical Circulatory Support for Takotsubo Syndrome With Shock: A Retrospective Multicenter Analysis.. 40:113-119. 2022
- Interatrial Stent to Treat Stiff Left Atrium Syndrome.. 40S:337-340. 2022
- Unloading a Broken Heart: Impella Support for Takotsubo Syndrome Complicated by Cardiogenic Shock.. 40:120-122. 2022
- Association of Chronic Renal Insufficiency With In-Hospital Outcomes in Primary Atrial Fibrillation Hospitalizations.. 37:145-146. 2022
- Japan-USA Orbital Atherectomy for Calcific Coronary Lesions: COAST Study, Harmonization by Doing Proof-of-Concept.. 37:112-117. 2022
- Intraprocedural Cardiac Complications of Transcatheter Aortic and Mitral Valve Interventions: "The Eyes Do Not See What the Mind Does Not Know".. 36:144-152. 2022
- Differential Outcomes With Edetate Disodium-Based Treatment Among Stable Post Anterior vs. Non-Anterior Myocardial Infarction Patients.. 21:1389-1395. 2020
- Incidence, Prognosis and Predictors of Major Vascular Complications and Percutaneous Closure Device Failure Following Contemporary Percutaneous Transfemoral Transcatheter Aortic Valve Replacement.. 21:1065-1073. 2020
- Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain: Rationale and Design of the FORECAST Trial.. 21:890-896. 2020
- Radial Artery Remodeling following Transradial Percutaneous Coronary Intervention in Men and Women: Insights from Serial Ultrahigh Frequency Ultrasonography.. 21:286-292. 2020
- Understanding operator stent choice in the catheterization laboratory using a pre-procedure survey: Opportunities for quality improvement.. 18:588-591. 2017
- Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement.. 18:169-176. 2017
- Acute myocardial infarction and cardiac arrest due to coronary artery perforation after mitral valve surgery: successful treatment with a covered stent.. 13:62-65. 2012
- Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents.. 13:111-118. 2012
- Association between ST segment Resolution following Fibrinolytic therapy or Intracoronary stenting, and Reinfarction in the same myocardial region in the DANAMI-2 study population.. 12:75-81. 2011
- The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study.. 12:273-279. 2011
- Preliminary observations using optical coherence tomography to assess neointimal coverage of a metal stent in a porcine model.. 10:229-235. 2009
- Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventions. 2016